Industry Partners

The SVS VQI works closely with industry using real-world registry data to advance the understanding of devices and therapies, improve patient safety, and streamline development.

Manufacturers can use the SVS VQI for retrospective or prospective projects to evaluate devices and therapies, working with the SVS PSO, FDA and Fivos:

• Take advantage of the existing network of over 1,000 SVS VQI centers participating in SVS VQI
• Reduce costs by simplifying site contracting, avoiding IRB fees
• Create dynamic content on the Fivos PATHWAYS web-based platform
• Supplement existing data with required elements to greatly speed project completion and meet regulatory requirements
• Provided necessary comparative device data as opposed to prospectively collecting this data over an estimated three years

Please see the latest documents describing industry projects:

• WEBINAR: Leveraging Real World Evidence Using the Vascular Quality Initiative
• 2023 SVS VQI Annual Report